News & Information

At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.

For Journalists

Connect with us to reach MSK experts for media inquiries, source story ideas and download MSK digital assets.

Learn more

In the News
Al Roker
TV anchor Al Roker discusses his own prostate cancer experiences, disparities in cancer care and outcomes for people of color, the importance of cancer screening for Black men, and more with Dr. Carol Brown, a gynecological oncology surgeon at Memorial Sloan Kettering and Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering.
View all articles
News Releases
View all news releases

Media Coverage


It’s the fourth most-commonly diagnosed cancer for U.S. women. So, why aren’t we talking more about it? MSK’s Mario Leitao is quoted.
Tuesday, April 20, 2021
While multiple myeloma is a rare cancer, there are lots of resources available to support people who have it. A good place to start is your own care team. MSK’s Michelle O’Hare and Urvi Shah are quoted.
Tuesday, April 20, 2021
The cancellation of the New York State Stem Cell Science program (NYSTEM) is contained in a budget for 2022, which the state Legislature approved last week and Governor Andrew Cuomo signed. The spending plan, which takes effect 1 May, halts funding for new grants, but honors existing contracts until they expire. MSK’s Lorenz Studer is quoted.
Monday, April 19, 2021

View all media coverage
News from the Lab
MSK News
View all MSK News
2019 Annual Report: It Starts with One
Brightly colored dots form a shape on a black background
Researchers in the Sloan Kettering Institute conducted a far-reaching analysis of single cells that is changing how we think about development.
Illustration of blood cells floating in the bloodstream
Liquid biopsies are shedding light on cancer DNA that’s hiding out in the bloodstream. MSK-ACCESS is one such test that took a big leap forward in 2019.
View the full report
Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
Upcoming Events
Find a complete list of events at MSK for everyone from patients and caregivers to physicians and researchers.
View all events